O
ORIC Pharmaceuticals, Inc. (ORIC)
NMS – Real vaqt narxi. Valyuta: USD
9.53
+0.07 (0.74%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
9.47
-0.06 (-0.63%)
Bozordan keyin: Jun 26, 2026, 7:59 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
9.53
+0.07 (0.74%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
9.47
-0.06 (-0.63%)
Bozordan keyin: Jun 26, 2026, 7:59 PM EDT
ORIC Pharmaceuticals, Inc., klinik bosqichdagi biofarmatsevtika kompaniyasi, Qo'shma Shtatlarda saratonning qarshilik mexanizmlariga qarshi kurashish uchun terapiyalarni kashf qilish va rivojlantirish bilan shug'ullanadi. Uning klinik bosqichdagi mahsulot nomzodlari orasida ilgari ORIC-114 nomi bilan tanilgan enozertinib, miyaga kiruvchi og'iz orqali bioavailabilityga ega bo'lgan qaytarilmas inhibitor, hozirda 1b faza tadqiqotida, u epidermis o'sish omili retseptorining (EGFR) ekzon 20 va inson epidermis o'sish omili retseptorining 2 ekzon 20 ni ekzon 20 qo'shimcha mutatsiyalariga yuqori samaradorlik bilan tanlab nishonga oladi; va ilgari ORIC-944 nomi bilan tanilgan rinzimetostat, prostata saratoni uchun polikom reppressiv kompleks 2 ning allosterik inhibitori, hozirda 1b faza tadqiqotida. Kompaniya Bayer bilan Nubeqa AR inhibitori bilan birgalikda ORIC-944 ni baholash bo'yicha klinik tadqiqotlar hamkorligi va ta'minot shartnomasiga ega; va Johnson & Johnson bilan Erleada AR inhibitori bilan birgalikda ORIC 944 ni baholash bo'yicha klinik tadqiqotlar hamkorligi va ta'minot shartnomasiga ega. Kompaniya 2014 yilda ro'yxatga olingan va Kaliforniyaning Janubiy San-Frantsisko shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Charles L. Sawyers B.A., M.D., Ph.D. | Founder & Member of Scientific Advisory Board |
| Dr. Christian V. Kuhlen Esq., J.D., M.D. | General Counsel |
| Dr. Jacob M. Chacko M.B.A., M.D. | President, CEO & Director |
| Dr. Kevin Brodbeck Ph.D. | Chief Technical Officer |
| Dr. Lori Sickels Friedman Ph.D. | Chief Scientific Officer |
| Dr. Pratik S. Multani M.D., M.S. | Chief Medical Officer |
| Dr. Richard A. Heyman Ph.D. | Founder, Independent Chairman & Member of Scientific Advisory Board |
| Dr. Scott W. Lowe Ph.D. | Founder & Member of Scientific Advisory Board |
| Mr. Daniel Iazzetti | VP & Head of People |
| Mr. Dominic G. Piscitelli CPA, M.B.A. | Chief Financial Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-04 | 8-K | oric-20260504.htm |
| 2026-05-04 | 10-Q | oric-20260331.htm |
| 2026-04-28 | DEFA14A | d938346ddefa14a.htm |
| 2026-04-28 | DEF 14A | d47769ddef14a.htm |
| 2026-04-28 | ARS | d938344dars.pdf |
| 2026-03-31 | 8-K | d133016d8k.htm |
| 2026-02-23 | 8-K | oric-20260223.htm |
| 2026-02-23 | 10-K | oric-20251231.htm |
| 2025-12-08 | 8-K | d46273d8k.htm |
| 2025-11-13 | 8-K | d898404d8k.htm |